References
- Tomson T, Dahl ML, Kimland E. Therapeutic monitoring of antiepileptic drugs for epilepsy. Cochrane Db Syst Rev 2007:2.
- Haymond J, Ensom MHH. Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder? Ther Drug Monit 2010;32:19–29.
- Patsalos PN, Berry DJ, Bourgeois BFD, Cloyd JC, Glauser TA, Johannessen SI, Leppik IE, Tomson T, Perucca E. Antiepileptic drugs – best practice guidelines for therapeutic drug monitoring. A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008; 49:1239–76.
- Patsalos PN, Berry DJ. Therapeutic drug monitoring of antiepileptic drugs by use of saliva. Ther Drug Monit 2013;35:4–29.
- Marsden D, Larson C, Levy HL. Newborn screening for metabolic disorders. J Pediatr 2006;148:577–84.
- Spooner N, Lad R, Barfield M. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method. Anal Chem 2009;81:1557–63.
- AbuRuz S, Al-Ghazawi M, Al-Hiari Y. A simple dried blood spot assay for therapeutic drug monitoring of lamotrigine. Chromatographia 2010;71:1093–9.
- la Marca G, Malvagia S, Filippi L, Fiorini P, Innocenti M, Luceri F, Pieraccini G, Moneti G, Francese S, Dani FR, Guerrini R. Rapid assay of topiramate in dried blood spots by a new liquid chromatography-tandem mass spectrometric method. J Pharmaceutand Biomed 2008;48: 1392–6.
- la Marca G, Malvagia S, Filippi L, Luceri F, Moneti G, Guerrini R. A new rapid micromethod for the assay of phenobarbital from dried blood spots by LC-tandem mass spectrometry. Epilepsia 2009;50:2658–62.
- Edelbroek PM, van der Heijden J, Stolk LML. Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls. Ther Drug Monit 2009;31:327–36.
- Timmerman P, White S, Globig S, Luedtke S, Brunet L, Smeraglia J. EBF recommendation on the validation of bioanalytical methods for dried blood spots. Bioanalysis 2011;3:1567–75.
- O’Mara M, Hudson-Curtis B, Olson K, Yueh Y, Dunn J, Spooner N. The effect of hematocrit and punch location on assay bias during quantitative bioanalysis of dried blood spot samples. Bioanalysis 2011;3:2335–47.
- Denniff P, Spooner N. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs. Bioanalysis 2010;2:1385–95.
- Paixao P, Gouveia LF, Morais JAG. Prediction of drug distribution within blood. Eur J Pharm Sci 2009;36:544–54.
- Kong ST, Lim WH, Wang HY, Ng YL, Ho PC, Lim S. Comparison of dried blood spots and plasma valproic acid and carbamazepine levels. Epilepsia 2012;53:116.
- Janis GC, Walker K, Collins JA. Determination of anticonvulsant drug concentrations in dried capillary blood spotted on filter paper. Epilepsia 2004;45:145.
- Fernandez-Campos F, Calpena A, Soy D, Colom H. Determination of total and unbound concentrations of valproic acid in human plasma by liquid chromatography-tamdem mass spectrometry. J Liq Chromatogr R T 2012; 35:1171–83.
- Matsuura K, Ohmori T, Nakamura M, Itoh Y, Hirano K. A simple and rapid determination of valproic acid in human plasma using a non-porous silica column and liquid chromatography with tandem mass spectrometric detection. Biomed Chromatogr 2008;22:387–93.
- Shibata M, Hashi S, Nakanishi H, Masuda S, Katsura T, Yano I. Detection of 22 antiepileptic drugs by ultra- performance liquid chromatography coupled with tandem mass spectrometry applicable to routine therapeutic drug monitoring. Biomed Chromatogr 2012;26:1519–28.
- Hwang K, Song SS, Lee JH, Shin MC, Seo JS. Development and validation of an LC/MS/MS method for determination of valproic acid and its metabolite 2-propyl-4-pentenoic acid in monkey plasma. J Korean Soc Appl Bi 2012;55:13–7.